Compare, Analyse Lupin with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 LUPIN   TEVA PHARMA
EQUITY SHARE DATA
    LUPIN
Mar-21
TEVA PHARMA
Dec-13
LUPIN/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,1223,099-   
Low Rs5762,692-   
Sales per share (Unadj.) Rs334.21,778.7-  
Earnings per share (Unadj.) Rs27.0111.1-  
Cash flow per share (Unadj.) Rs46.6254.9-  
Dividends per share (Unadj.) Rs6.5097.27-  
Dividend yield (eoy) %0.83.4 22.8%  
Book value per share (Unadj.) Rs300.11,975.8-  
Shares outstanding (eoy) m453.68848.00-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.51.6 156.0%   
Avg P/E ratio x31.426.1 120.5%  
P/CF ratio (eoy) x18.211.4 160.3%  
Price / Book Value ratio x2.81.5 193.0%  
Dividend payout %24.087.5 27.5%   
Avg Mkt Cap Rs m385,0722,455,596 15.7%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m28,2590-   
Avg. sales/employee Rs ThNM33,559.1-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,096.4-  
INCOME DATA
Net Sales Rs m151,6301,508,315 10.1%  
Other income Rs m1,3630-   
Total revenues Rs m152,9931,508,315 10.1%   
Gross profit Rs m25,669413,053 6.2%  
Depreciation Rs m8,874121,919 7.3%   
Interest Rs m1,40629,626 4.7%   
Profit before tax Rs m16,751261,509 6.4%   
Minority Interest Rs m01,188 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-171,666 0.0%   
Tax Rs m4,485-3,193 -140.5%   
Profit after tax Rs m12,26694,223 13.0%  
Gross profit margin %16.927.4 61.8%  
Effective tax rate %26.8-1.2 -2,193.1%   
Net profit margin %8.16.2 129.5%  
BALANCE SHEET DATA
Current assets Rs m139,8641,018,710 13.7%   
Current liabilities Rs m84,361888,401 9.5%   
Net working cap to sales %36.68.6 423.7%  
Current ratio x1.71.1 144.6%  
Inventory Days Days6991 76.2%  
Debtors Days Days10896 112.3%  
Net fixed assets Rs m94,439492,649 19.2%   
Share capital Rs m9073,713 24.4%   
"Free" reserves Rs m135,2290-   
Net worth Rs m136,1361,675,451 8.1%   
Long term debt Rs m161771,235 0.0%   
Total assets Rs m234,3023,446,982 6.8%  
Interest coverage x12.99.8 131.4%   
Debt to equity ratio x00.5 0.3%  
Sales to assets ratio x0.60.4 147.9%   
Return on assets %5.83.6 162.4%  
Return on equity %9.05.6 160.2%  
Return on capital %13.34.9 270.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m29,9460-   
CASH FLOW
From Operations Rs m18,218240,347 7.6%  
From Investments Rs m-12,396-85,165 14.6%  
From Financial Activity Rs m-18,853-288,313 6.5%  
Net Cashflow Rs m-13,031-133,130 9.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 74.25 Rs / USD

Compare LUPIN With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare LUPIN With: SMS PHARMA  NEULAND LABS  J.B.CHEMICALS  GENNEX LAB.  TTK HEALTHCARE  



Today's Market

Sensex, Nifty Open Flat; Tech Mahindra Zooms 8% Post June Quarter Results(09:30 am)

Asian share markets are trading on a negative note today as risks of China crackdown still loomed.

Related Views On News

Lupin Gains 16% in a Month. Here's Why it Could Rally More (Views On News)

Jun 4, 2021

Recent developments in digital healthcare and revised targets by brokerages send Lupin shares flying.

LUPIN 2019-20 Annual Report Analysis (Annual Result Update)

Dec 7, 2020 | Updated on Dec 7, 2020

Here's an analysis of the annual report of LUPIN for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (2QFY21); Net Profit Up 271.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, LUPIN has posted a net profit of Rs 2 bn (up 271.3% YoY). Sales on the other hand came in at Rs 38 bn (down 12.0% YoY). Read on for a complete analysis of LUPIN's quarterly results.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Glenmark Life Sciences IPO Opens Tomorrow: Few Points to Know Before Applying (Views On News)

Jul 26, 2021

All you need to know about the IPO of Glenmark Life Sciences.

More Views on News

Most Popular

These Are the Best Stocks to Own (Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

Cash the Crash in Gas Prices (Fast Profits Daily)

Jul 21, 2021

Get ready to profit from the coming crash in the price of natural gas.

Electric 2-Wheelers: The Megatrend has Begun (Profit Hunter)

Jul 20, 2021

The shift to electric 2-wheelers will be faster than expected.

A Trading Hack to Multiply Profits (Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

OPEC & Our Next Crude Oil Trade (Fast Profits Daily)

Jul 20, 2021

This is why we are on the correct side of the crude oil trade.

More
-->

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

LUPIN SHARE PRICE


Jul 30, 2021 11:54 AM

TRACK LUPIN

MORE ON LUPIN

LUPIN - VAISHALI PHARMA COMPARISON

COMPARE LUPIN WITH

FEATURED VIDEOS

What is the Best Time to Sell a Stock?

What Will Make You Rich Faster: Investing or Trading?

CRISIL v/s CARE Ratings: An Interesting Comparison

The 3-Word Secret to Earning Incredible Returns

More Featured Videos

MARKET STATS